Back to results
US 2024/0180919 A1Published application
Ezh2 inhibitors for treating cancer
AssigneeEpizyme, Inc.
InventorsScott RIBICH, Michael THOMENIUS
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and one or more other therapeutic agents, for example, modulators of CD40 pathway activity, such as CD40 agonists, and methods of combination therapy for administering to subjects in need thereof for the treatment of cancer.
Claims18
A method for treating a cancer in a subject in need thereof comprising administering a therapeutically effective amount of an EZH2 inhibitor and a second therapeutic agent.
Dependencies are inferred from the claim text.